The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

Water and the bad smelling molecule hydrogen sulfide do not seem to have a lot in common at first sight. However, when ...

Key Business Updates BRUKINSA ® (zanubrutinib) is an orally available, small molecule inhibitor of BTK designed to deliver ...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...

In addition, it can allow the buildup of a small molecule known as methylmalonic acid (MMA). In healthy tissues, vitamin B12 helps break down MMA. In B12 deficient patients, MMA is increased and can ...

Cash Position : The Company's cash position as of September 30, 2024, was $41.6 million compared to $9.4 million as of December 31, 2023. This increase is largely due to proceeds from the private ...

When tested in mice, the compound—named BBI-2779—shrank gastric tumors and prevented the cancer from developing resistance to ...